SOLID DISPERSION: A NOVEL APPROACH FOR POORLY WATER SOLUBLE DRUGS
Keywords:Dispersion, Carrier, Solubility, Characterization
Objective: Out of newly discovered drugs more than 40% pharmacologically active molecule having poor solubility. This is one of the serious challenge in the pharmaceutical industry and commercialization of the drug.
Methods: With the introduction of new manufacturing technologies such as solid dispersion pH modification, SEED, salt formation, co crystallization.
Results: it should be possible to overcome problems. Potential of solid dispersion technology has been well established for hydrophobic agents because of ease of optimization, simplicity and easy scale up.
Conclusion: This article begins with an overview of the historical background and definition and importance of solubility and solid dispersion. The remainder of the article is devoted to the production, the different carriers and the methods used for the characterization of solid dispersions.
Wu CY, Benet LZ. Predicting drug disposition via application of BCS: Transport/Absorption/Elimination interplay and development of a biopharmaceutics drug disposition classification system. Pharm Res 2005;22:11-23.
Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm Res 1995;12:413-20.
Hancock BC, George Z. Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 1997;86:1-12.
Murdande SB, Pikal MJ, Shanker RM, Bogner RH. Solubility advantage of amorphous pharmaceuticals: Athermodynamic analysis. J Pharm Sci 2009;99:1254-64.
Choudhary D, Kumar S, Gupta GD. Solubility enhancement of glipizide by solid dispersion (kneading) technique. Asian J Pharm 2009;3:245-51.
Yu L. Amorphous pharmaceutical solids: preparation, characterization and stabilization. Adv Drug Delivery Rev 2001;48:27-42.
Konno H, Taylor LS. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipin. J Pharm Sci 2006;95:2692-705.
Pokharkar VB. Development, characterization and stabilization of amorphous form of a low Tg drug. Powder Technol 2000;167:20â€“5.
Van den Mooter G. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int J Pharm 2006;316:1â€“6.
Vasanthavada M. Phase behavior of amorphous molecular dispersion: Determination of the degree and mechanism of solid solubility. Pharm Res 2004;21:1598â€“606.
Taylor LS, Zografi G. Spectroscopic characterization of interactions between PVP and indomethacin in amorphous molecular dispersions. Pharm Res 1997;14:1691â€“8.
Zhou D. A calorimetric investigation of thermodynamic and molecular mobility contributions to the physical stability of two pharmaceutical glasses. J Pharm Sci 2007;96:71â€“83.
Yoshioka M. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature. J Pharm Sci 1984;83:1700â€“5.
Gunawan L. Structural relaxation of acetaminophen glass. Pharm Res 2006;23:967â€“79.
Zhou D. Physical stability of amorphous pharmaceuticals: Importance of configurational thermodynamic quantities and molecular mobility. J Pharm Sci 2002;91:1863â€“72.
Konno H, Taylor LS. Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 2006;95:2692â€“705.
Vippagunta SR. Factors affecting the formation of eutectic solid dispersions and their dissolution behavior. J Pharm Sci 2006;96:294â€“304.
Vasconcelos T, Sarmanto B, Costa P. Solid dispersion as strategy to improve oral bioavailability of poorly water soluble drugs. J Pharm Sci 2007;12:1068-75.
Liu R. Water-Insoluble drug formulation. New York: 2nd ed. CRC Press; 2008. p. 522.
Leuner C, Dressman J. Improving drug solubility for oral delivery using solid dispersions. Eur J Pharm Biopharm 2000;50:47â€“60.
Sekiguchi K, Obi N. Studies on absorption of eutectic mixtures, I. A comparison of the behavior of eutectic mixtures of sulphathiozole and that of ordinary sulphathiozole in man. Chem Pharm Bull 1961;9:866-72.
Yoshioka MB, Hancock C, Zogra G. Inhibition of indomethacin crystallization in poly (vinylpyrrolidone) coprecipitates. J Pharm Sci 1995;84:983â€“6.
Kapoor B, Kour S, Behl H, Kour S. Solid dispersion: an evolutionary approach for solubility enhancementof poorly water soluble drugsinternational. J Recent Adv Pharm Res 2012;2:1-16.